As a child nutritionist and a mom of twins, I've noticed a troubling pattern in my practice: eczema cases in young Indian ...

INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...

During the cold winter months, many people notice their skin’s condition worsens. Dry air and indoor heating can exacerbate symptoms of eczema, or atopic dermatitis. This leads to dry, cracked ...

With shares down more than 40% since November, the risk-reward for Nektar Therapeutics has shifted ahead of pivotal clinical ...

Topical pumecitinib 3% gel shows strong efficacy and good tolerability in mild-to-moderate atopic dermatitis. Explore the ...

Amlitelimab is effective at improving moderate to severe AD across all body regions, including the difficult-to-treat head and neck region.

Kyowa Kirin will file for rocatinlimab’s US approval, which was once Amgen’s most late-stage pipeline candidate.

Skin is increasingly understood as a reflection of internal balance rather than a problem limited to the surface. Conditions ...

Amgen (NasdaqGS:AMGN) ended its eczema drug partnership with Kyowa Kirin involving the experimental therapy rocatinlimab. The ...

The TV star opened up in 2022 about painful flare-ups that left her feeling self-conscious ...

A Phase III readout in September 2024 for rocatinlimab, on which Amgen and Kyowa Kirin were collaborating in atopic dermatitis, appeared underwhelming to analysts, with Jefferies noting that the data ...

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like arthritis, IBD, allergies, and more.